Cardiovascular risk assessment in oncologic patients. A narrative review.
Cancer patients benefit from systematic heart disease assessment before and during treatment to prevent therapy-related cardiac damage.
Oncology patients require systematic cardiovascular risk assessment integrating cancer-associated risk factors, treatment cardiotoxicity, and comorbidities within an integrated cardio-oncology framework. This record was retained from the prior triage attempt for PubMed pipeline handoff.
What the study was
- Study design
- narrative_review
- Category
- cardiovascular_metabolic
- Maturity
- Exploratory
- Journal
- Hellenic Journal of Nuclear Medicine
Why it surfaced
Cardio-oncology risk assessment review; relevant to cardiometabolic monitoring in cancer treatment pipeline.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.